Hepion Historical Income Statement
| HEPA Stock | USD 2.11 0.02 0.94% |
Historical analysis of Hepion Pharmaceuticals income statement accounts such as Other Operating Expenses of 50.9 M or Research Development of 37.4 M can show how well Hepion Pharmaceuticals performed in making a profits. Evaluating Hepion Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Hepion Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Hepion Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hepion Pharmaceuticals is a good buy for the upcoming year.
Hepion |
About Hepion Income Statement Analysis
Hepion Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Hepion Pharmaceuticals shareholders. The income statement also shows Hepion investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Hepion Pharmaceuticals Income Statement Chart
Hepion Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Hepion's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Hepion Pharmaceuticals revenue and expense. Hepion Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Hepion Pharmaceuticals' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 50.9 M, whereas Selling General Administrative is forecasted to decline to about 6.5 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Hepion Pharmaceuticals. It is also known as Hepion Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Hepion Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Hepion Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.At present, Hepion Pharmaceuticals' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 50.9 M, whereas Selling General Administrative is forecasted to decline to about 6.5 M.
Hepion Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Hepion Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hepion Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 26.7K | 34.5K | 86.1K | 77.5K | 69.7K | 83.9K | |
| Selling General Administrative | 4.6M | 8.1M | 10.0M | 10.3M | 9.6M | 6.5M | |
| Other Operating Expenses | 7.8M | 20.1M | 30.4M | 43.6M | 48.4M | 50.9M | |
| Operating Income | (7.8M) | (20.1M) | (30.4M) | (45.5M) | (48.4M) | (46.0M) | |
| Ebit | (7.9M) | (20.1M) | (30.4M) | (43.6M) | (39.3M) | (37.3M) | |
| Research Development | 3.2M | 12.0M | 20.4M | 33.3M | 35.6M | 37.4M | |
| Ebitda | (7.9M) | (20.1M) | (30.3M) | (43.5M) | (48.4M) | (46.0M) | |
| Total Operating Expenses | 7.8M | 20.1M | 30.4M | 43.6M | 48.4M | 50.9M | |
| Income Before Tax | (7.9M) | (20.3M) | (32.7M) | (45.1M) | (49.3M) | (46.9M) | |
| Total Other Income Expense Net | 379.1K | (146.1K) | (2.3M) | (1.5M) | (887.1K) | (842.8K) | |
| Net Income | (7.0M) | (20.4M) | (32.7M) | (42.2M) | (48.9M) | (46.5M) | |
| Income Tax Expense | (908.7K) | 30.6K | 8.9K | (2.9M) | 409.0K | 429.5K | |
| Interest Expense | 555.0K | 31.2K | 8.9K | 10.2K | 9.5K | 9.0K | |
| Net Income Applicable To Common Shares | (12.2M) | (20.4M) | (32.7M) | (45.3M) | (40.8M) | (38.8M) | |
| Net Income From Continuing Ops | (6.7M) | (20.4M) | (32.7M) | (42.2M) | (44.7M) | (42.4M) | |
| Tax Provision | (1.2M) | 30.6K | (2.9K) | (2.9M) | (2.6M) | (2.5M) | |
| Reconciled Depreciation | 26.7K | 34.5K | 86.1K | 77.5K | 73.3K | 54.2K | |
| Net Interest Income | (555.0K) | (31.2K) | (8.9K) | (10.2K) | (9.6K) | (10.0K) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hepion Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hepion Pharmaceuticals' short interest history, or implied volatility extrapolated from Hepion Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Hepion Stock analysis
When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Hepion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.42) | Return On Assets (0.63) | Return On Equity (1.18) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.